Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14).

Authors:
Ceglédi A; Csukly Z; Fekete M; Kozma A; Szemlaky Z and 2 more

Journal:
Pathol Oncol Res

Publication Year: 2023

DOI:
10.3389/pore.2023.1611375

PMCID:
PMC10668022

PMID:
38025905

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pathol Oncol Res

Abbreviation: Pathol Oncol Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Clinical significance of integrin αV and β superfamily members and focal adhesion kinase activity i…
Sakurai S; Ishida Y; Shintani T and 6 more (2024) - Transparency Score: 2/6
Extracellular vesicles as modulators of glioblastoma progression and tumor microenvironment.
Dai J; Jiang Y; Hu H and 2 more (2024) - Transparency Score: 2/6
LINAC-based SBRT in treating early-stage NSCLC patients-single institution experience and survival …
Kovács Á; Trási K; Barabás M and 5 more (2024) - Transparency Score: 2/6
Stereotactic body radiotherapy in lung cancer: a contemporary review.
Csiki E; Simon M; Papp J and 5 more (2024) - Transparency Score: 2/6
3D bioprinting and the revolution in experimental cancer model systems-A review of developing new m…
Sztankovics D; Moldvai D; Petővári G and 5 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest GM received research funding and honoraria from AbbVie. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"Author contributions: GM, AC, ZC, and ZS: treated the patients. AC and MF wrote the initial manuscript. AC, AK, HA, and GM: analyzed the data, all authors contributed the revised versions of the manuscript. GM conceptualized the study, obtained the necessary permission and treatment funding coverage and supervised the entire study."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025